Cleave Therapeutics, Inc.
Records under this name other than the patents Cleave Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 3 of 3 · Back to Cleave Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,435,085 | Crystalline forms and formulations of a VCP/p97 inhibitor Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,010,554 | Fused Pyrimidines as Inhibitors of P97 Complex Lapsed on the fee record Ended Jul 3, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 3, 2026 | Medium confidence |
| US 9,868,722 | Monocyclic pyrimidine/pyridine compounds as inhibitors of P97 complex Lapsed on the fee record Ended Jan 16, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 16, 2026 | USPTO record |